Online Training

The ‘Smoking Cessation Brief Advice Training for Primary Health Care Nurses’ is designed to support smoking cessation care in nursing. It will equip nurses with the skills, confidence and knowledge to provide smoking cessation brief advice to patients who smoke. 

This activity has been endorsed by APNA according to approved quality standards criteria 

Completion of these educational activities entitles eligible participants to claim 1 CPD hours 

This education has been approved as a Lung Learning Quality-Assured Activity.

Duration: 60 minutes 

Cost: Free 

Learning objectives: 

• Describe the negative health and social impacts of smoking 

• Discuss the use of the AAH brief advice model of cessation care, explain the role of multi-sessional behavioural intervention (e.g. Quitline), describe the process of referral to Quitline, and Identify resources available to support patients on their smoking cessation journey 

• Outline the currently available smoking cessation pharmacotherapies, discuss clinical considerations for their use, and explain methods for effectively managing nicotine withdrawal symptoms 

• Identify clinically significant drug interactions associated with smoking and stopping smoking 

The ‘Smoking Cessation Brief Advice Training for General Practitioners’ is designed to support smoking cessation care in general practice. It will equip general practitioners with the skills, confidence and knowledge to provide smoking cessation brief advice to patients who smoke. 

This education has been approved as a Lung Learning Quality-Assured Activity.

Duration: 60-90 minutes

Cost: Free

Learning outcomes:

• Describe the negative impact smoking has on physical and mental health, and social outcomes.

• Discuss the use of the three-step (Ask, Advise, Help) model of brief advice for smoking cessation in clinical practice.

• Explain how currently available smoking cessation pharmacotherapy options may be used effectively to reduce withdrawal symptoms and minimise side effects.

• Identify and manage common and clinically significant drug interactions associated with smoking and stopping smoking.

The 'Nicotine Vaping Products: Considerations for GP's' training provides information and evidence-based guidance to GPs on the practicalities of prescribing nicotine vaping products for smoking cessation in the new regulatory environment, including how to maximise benefit and minimise risk.

Duration: 60 minutes

Cost: Free

Learning outcomes:

• Explain the current legal and regulatory framework for nicotine vaping products in Australia

• Discuss the currently available evidence for the use of nicotine vaping products in smoking cessation, and the potential risks and benefits

• Outline the current RACGP recommendations for the clinical use of nicotine vaping products in primary care

• Describe the key factors to consider when prescribing nicotine vaping products for patients.

The ‘Smoking Cessation Brief Advice Training for Pharmacists’ is designed to support smoking cessation care in pharmacy. It will equip pharmacists with the skills, confidence and knowledge to provide smoking cessation brief advice to patients who smoke.

This activity has been accredited by the PSA for 1.5 hours of Group 1 CPD (or 1.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1.5 hours of Group 2 CPD (or 3 CPD credits) upon successful completion of relevant assessment activities.

This education has been approved as a Lung Learning Quality-Assured Activity.

Duration: 90 minutes

Cost: Free

Learning objectives:

• Describe evidence-based smoking cessation care

• Explain the pharmacist’s role in smoking cessation, including the importance of implementing the three-step smoking cessation brief advice (Ask, Advise, Help; AAH) model of care

• Explain the important role of multi-sessional behavioural intervention for smoking cessation (e.g. through Quitline) and describe how to refer patients

• Explain how to assess nicotine dependence and recognise the signs of nicotine withdrawal

• Describe the different pharmacotherapy options including clinical considerations and practice points

• Identify and manage clinically significant drug interactions associated with stopping smoking

This module is temporarily unavailable.

For information, pharmacists can refer to the TGA’s Vapes: information for pharmacists.

Quit Centre was part of a webinar in February 2024 with TGA and PSA which provided an important opportunity for pharmacists to hear about the regulatory reforms and what these changes mean. Clearing the Air- Navigating Vaping Reforms with Confidence

Duration: 60 minutes

Cost: Free

Learning objectives:

• Understand the smoking prevalence in pregnant women and which priority populations have higher rates of smoking in pregnancy

• Describe the health impacts of smoking in pregnancy

• Know how to provide fast, simple and effective brief advice in a supportive, non-judgmental manner

• Recognise the important role of multi-session behavioural intervention (Quitline, including Aboriginal Quitline) and know how to refer

• Understand the considerations for pharmacotherapy use in pregnancy and breastfeeding, and the different types and formulations available

• Know how to respond to common scenarios and myths you may encounter while supporting pregnant women to stop smoking